3 completed, 1 terminated. 3 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Evolva SA: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Resveratrol Supplementation on Inflammation and Cognitive Performance in Healthy Adults Resveratrol, Placebo - Cognitive Change, Mood | Not applicable | Completed | Northumbria University | 100 | 2019-03-19 | 2020-03-19 |
| The Effects of Resveratrol Supplementation on Cognition, Cerebral Blood Flow, Microbiota and Systemic Inflammation. Resveratrol, Placebo - Cognitive Function and Mood, Cerebral Blood Flow | Not applicable | Completed | Northumbria University | 110 | 2018-02-06 | 2020-03-17 |
| Impact of Resveratrol on Brain Function and Structure resveratrol supplementation, Placebo - Healthy | Not applicable | Completed | Max Planck Institute for Human Cognitive and Brain Sciences | 60 | 2016-04-01 | 2017-02-08 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects EV-077, Placebo - Type 2 Diabetes | Phase 2 | Terminated | Evolva SA | 33 | 2012-01-01 | 2013-06-17 |
Diabetes Mellitus, Type 2 (1) · Inflammation (1) · Obesity (1) · Overweight (1)
Resveratrol (2)
Germany (2) · United Kingdom (2)
Arno Villringer (1) · Arno Villringer, Prof. (1) · Emma L Wightman, Dr (1) · Emma Wightman, Dr (1) · Thomas Jax, MD (1) · Veronica Witte (1)